The Zodiak Trial: Protocol of a Double-Blind, Placebo-Controled, Two-Year Clinical Trial of Zoledronic Acid as a Disease-Modifying Drug in Knee Osteoarthritis With Bone Marrow Lesions

Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2019.02.563

Related search